Speech-language characteristics of children with neurofibromatosis type 1

American Journal of Medical Genetics. Part a
Heather L ThompsonKathy L Chapman

Abstract

Delays in speech and articulation development have been found in school-aged children and adolescents with neurofibromatosis type 1 (NF1). This report examines speech and language skills of preschool children with NF1. Nineteen 3- to 5-year-old children diagnosed with NF1 were assessed using measures of articulation (GFTA-2), and receptive and expressive language (CELF-P2). Significant differences were observed between mean scores obtained by the group of children with NF1 compared to the validated controls from the speech and language instruments (P < or = 0.009). Sixty-eight percent of the children exhibited delays in speech and/or language. Thirty-two percent demonstrated delays in articulation, 37% percent demonstrated delays in receptive language, and 37% exhibited delays in expressive language. Sixteen percent of the children exhibited a voice disorder and 42% were judged to have a resonance problem. No significant differences were observed on any of the measures of speech and language for children with non-familial versus familial NF1. Results of this study support the need for early assessment of speech and language problems for children diagnosed with NF1 and implementation of appropriate timely intervention as needed.

References

Jan 1, 1992·Journal of Learning Disabilities·A S Bashir, A Scavuzzo
Aug 1, 1991·Journal of Speech and Hearing Research·P MenyukA Belanger
Nov 1, 1990·Journal of Child Psychology and Psychiatry, and Allied Disciplines·D V Bishop, C Adams
May 1, 1989·The Journal of Speech and Hearing Disorders·J B Tomblin
Jul 1, 1989·American Journal of Diseases of Children·R EldridgeM A Zasloff
May 1, 1988·The Journal of Speech and Hearing Disorders·L D Shriberg, J Kwiatkowski
Jun 1, 1984·Journal of Speech and Hearing Research·D M AramJ E Nation
Sep 1, 1981·International Journal of Pediatric Otorhinolaryngology·M A Pollack, R J Shprintzen
Jan 1, 1982·The American Journal of Cardiology·G S MintzM N Kotler
Apr 1, 1995·Journal of Speech and Hearing Research·J BirdN H Freeman
Oct 1, 1993·Journal of Speech and Hearing Research·H W Catts
Aug 1, 1996·Journal of Developmental and Behavioral Pediatrics : JDBP·C V DiltsC O Leonard
Feb 12, 1998·Journal of Speech, Language, and Hearing Research : JSLHR·J B TomblinM O'Brien
Dec 1, 1998·Folia Phoniatrica Et Logopaedica : Official Organ of the International Association of Logopedics and Phoniatrics (IALP)·K Nauclér, E Magnusson
Dec 22, 1999·Journal of Speech, Language, and Hearing Research : JSLHR·L D ShribergJ L McSweeny
May 10, 2001·International Journal of Language & Communication Disorders·M J SnowlingS E Stothard
Jan 28, 2003·Journal of Speech, Language, and Hearing Research : JSLHR·Hugh W CattsXuyang Zhang
Apr 23, 2003·Child Development·Thomas F CampbellMarcia Kurs-Lasky
Dec 1, 1962·Brain : a Journal of Neurology·E DE RENZI, L A VIGNOLO
Apr 3, 2004·Trends in Plant Science·Amit GurDani Zamit
Feb 3, 2006·Pediatrics·UNKNOWN US Preventive Services Task Force
Jun 20, 2006·American Journal of Speech-language Pathology·Susan Rvachew
Jul 4, 2006·Journal of Fluency Disorders·Julie D AndersonNancy E Hall
Jan 2, 2007·Journal of Speech, Language, and Hearing Research : JSLHR·Laura Segebart DeThorneMegan Dunn Davison

❮ Previous
Next ❯

Citations

Aug 19, 2011·Current Treatment Options in Neurology·Simone L Ardern-Holmes, Kathryn N North
Dec 24, 2011·Journal of Communication Disorders·Marjan CosynsJohn Van Borsel
May 10, 2011·Journal of Voice : Official Journal of the Voice Foundation·Marjan CosynsJohn Van Borsel
Nov 26, 2010·The Journal of Pediatrics·Jennifer LorenzoKathryn North
Oct 19, 2010·Journal of Voice : Official Journal of the Voice Foundation·Marjan CosynsJohn Van Borsel
Nov 5, 2011·American Journal of Medical Genetics. Part a·Marjan CosynsJohn Van Borsel
Apr 10, 2014·American Journal of Medical Genetics. Part a·Jade TinkerDavid A Stevenson
Dec 19, 2013·International Journal of Pediatrics·Bonita P Klein-TasmanJasmine A Walker
Jul 6, 2014·Research in Developmental Disabilities·Natalie G BreiChristina L Casnar
Apr 19, 2018·Developmental Medicine and Child Neurology·Shelley S ArnoldBelinda Barton
Jun 20, 2017·American Journal of Medical Genetics. Part a·André B RietmanPieter F A de Nijs
Aug 11, 2018·Orphanet Journal of Rare Diseases·Vivian VisnapuuJuha Peltonen
Jun 20, 2018·Journal of Neurodevelopmental Disorders·Elizabeth I PierpontChristopher L Moertel
Jun 5, 2021·The Cleft Palate-craniofacial Journal : Official Publication of the American Cleft Palate-Craniofacial Association·Alison L BirchJohn G Boorman
Oct 1, 2021·Child Neuropsychology : a Journal on Normal and Abnormal Development in Childhood and Adolescence·Kristina M HaebichJonathan M Payne

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

American Journal of Medical Genetics. Part a
Lotta AlivuotilaJuha Peltonen
International Journal of Language & Communication Disorders
Marjan CosynsJohn Van Borsel
The New England Journal of Medicine
V M Riccardi
Current Opinion in Neurology
Ming-Jen Lee, Dennis A Stephenson
© 2021 Meta ULC. All rights reserved